Target Name: FSCN3
NCBI ID: G29999
Other Name(s): testis fascin | Fascin 3 | fascin actin-bundling protein 3 | FSCN3_HUMAN | Fascin actin-bundling protein 3 | Fascin-3 | Testis fascin | testicular secretory protein Li 18 | fascin actin-bundling protein 3, testicular | fascin homolog 3, actin-bundling protein, testicular

FSCN3: A Drug Target / Disease Biomarker

FSCN3 is a protein that is expressed in the heart and has been identified as a potential drug target or biomarker for various cardiovascular diseases, including heart failure, hypertension, and cardiovascular amyloidosis. FSCN3 is a key regulator of the fibroblast growth and is involved in the development and maintenance of cardiac muscle cells.

Studies have shown that FSCN3 is highly expressed in the heart and that it is involved in the regulation of various cardiac functions, including contractility, heart rate, and fibrosis. FSCN3 has also been shown to play a role in the development of cardiac arrhythmias and has been linked to the development of certain cardiovascular diseases.

FSCN3 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This is important for the development of new blood vessels, which is necessary for delivering oxygen and nutrients to the heart muscle.

FSCN3 has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is important for the regulation of cell growth, differentiation, and survival, and is a potential target for new drugs.

In addition to its role in cellular signaling pathways, FSCN3 has also been shown to be involved in the regulation of gene expression. This is important for the regulation of cellular processes and is a potential target for new drugs.

Overall, FSCN3 is a protein that is involved in a number of important cellular processes that are involved in the development and maintenance of cardiac muscle cells. As a result, FSCN3 is a potential drug target or biomarker for a variety of cardiovascular diseases. Further research is needed to fully understand the role of FSCN3 in these diseases and to develop new treatments.

Protein Name: Fascin Actin-bundling Protein 3

Functions: Acts as an actin bundling protein

More Common Targets

FSD1 | FSD1L | FSD2 | FSHB | FSHR | FSIP1 | FSIP2 | FSIP2-AS2 | FST | FSTL1 | FSTL3 | FSTL4 | FSTL5 | FTCD | FTCDNL1 | FTH1 | FTH1P1 | FTH1P10 | FTH1P11 | FTH1P12 | FTH1P2 | FTH1P20 | FTH1P22 | FTH1P24 | FTH1P3 | FTH1P4 | FTH1P5 | FTH1P7 | FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2